In this study, among 417 patients diagnosed or suspected of Alport syndrome in our department during 2014–2017, six were identified with pathogenic variants in COL4A5 plus heterozygous pathogenic variants in COL4A3 or COL4A4, which accounted for 1%. The gene discussed is COL4A3; the disease is Alport syndrome.